Bacillus coagulans MTCC 5856 and Improved Gastrointestinal Discomfort

• Bacillus coagulans MTCC 5856 for the management of major depression with irritable bowel syndrome: a randomised, double-blind, placebo controlled, multi-centre, pilot clinical study

  • 2018-07-04
  • RCT · n = 40
  • Food & Nutrition Research 62(0)
  • • M. Majeed
    • K. Nagabhushanam
    • S. Arumugam
    • Shaheen Majeed
    • Furqan Ali

  • PubMed: 29997457
  • DOI: 10.29219/fnr.v62.1218

  9 Insights on

  • Improved Gastrointestinal Discomfort

  • High evidence
  • Highly Cited
  • Rigorous Journal

  Secondary efficacy measures i.e. ... Gastrointestinal Discomfort Questionnaire (GI-DQ) ... also showed significant results (p = 0.01) in B. coagulans MTCC 5856 group compared to placebo group

  Effect

  Beneficial

  Effect size

  Moderate

  Significant

  Yes

  Dose

  2 × 10^9 cfu (2 billion spores) daily